nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisone—CYP3A4—Temozolomide—malignant glioma	0.119	1	CbGbCtD
Prednisone—Wound—Carmustine—malignant glioma	0.034	0.0649	CcSEcCtD
Prednisone—Monoplegia—Carmustine—malignant glioma	0.0319	0.0609	CcSEcCtD
Prednisone—Cushing's syndrome—Carmustine—malignant glioma	0.0217	0.0415	CcSEcCtD
Prednisone—Pigmentation disorder—Temozolomide—malignant glioma	0.0143	0.0273	CcSEcCtD
Prednisone—HSD11B1—telencephalon—malignant glioma	0.0139	0.115	CbGeAlD
Prednisone—Meningitis—Carmustine—malignant glioma	0.0127	0.0243	CcSEcCtD
Prednisone—Opportunistic infection—Temozolomide—malignant glioma	0.0118	0.0226	CcSEcCtD
Prednisone—Intracranial pressure increased—Carmustine—malignant glioma	0.0118	0.0226	CcSEcCtD
Prednisone—Impaired healing—Carmustine—malignant glioma	0.0114	0.0218	CcSEcCtD
Prednisone—HSD11B1—medulla oblongata—malignant glioma	0.0109	0.0901	CbGeAlD
Prednisone—HSD11B1—midbrain—malignant glioma	0.01	0.0823	CbGeAlD
Prednisone—HSD11B1—spinal cord—malignant glioma	0.00976	0.0803	CbGeAlD
Prednisone—Lymphopenia—Temozolomide—malignant glioma	0.00931	0.0178	CcSEcCtD
Prednisone—Febrile neutropenia—Carmustine—malignant glioma	0.0082	0.0157	CcSEcCtD
Prednisone—Febrile neutropenia—Temozolomide—malignant glioma	0.00792	0.0151	CcSEcCtD
Prednisone—HSD11B1—central nervous system—malignant glioma	0.00792	0.0652	CbGeAlD
Prednisone—HSD11B1—cerebellum—malignant glioma	0.00774	0.0637	CbGeAlD
Prednisone—Embolism—Temozolomide—malignant glioma	0.00742	0.0142	CcSEcCtD
Prednisone—Myopathy—Temozolomide—malignant glioma	0.0068	0.013	CcSEcCtD
Prednisone—Necrosis—Carmustine—malignant glioma	0.00628	0.012	CcSEcCtD
Prednisone—HSD11B1—brain—malignant glioma	0.00628	0.0517	CbGeAlD
Prednisone—Abscess—Carmustine—malignant glioma	0.00623	0.0119	CcSEcCtD
Prednisone—Memory impairment—Temozolomide—malignant glioma	0.00607	0.0116	CcSEcCtD
Prednisone—Petechiae—Temozolomide—malignant glioma	0.00579	0.0111	CcSEcCtD
Prednisone—Endocrine disorder—Temozolomide—malignant glioma	0.00575	0.011	CcSEcCtD
Prednisone—Amenorrhoea—Temozolomide—malignant glioma	0.00542	0.0104	CcSEcCtD
Prednisone—Viral infection—Temozolomide—malignant glioma	0.00528	0.0101	CcSEcCtD
Prednisone—Leukocytosis—Carmustine—malignant glioma	0.00525	0.01	CcSEcCtD
Prednisone—Skin exfoliation—Carmustine—malignant glioma	0.00471	0.009	CcSEcCtD
Prednisone—Neuropathy—Carmustine—malignant glioma	0.00463	0.00885	CcSEcCtD
Prednisone—Skin exfoliation—Temozolomide—malignant glioma	0.00455	0.00869	CcSEcCtD
Prednisone—Neuropathy—Temozolomide—malignant glioma	0.00447	0.00855	CcSEcCtD
Prednisone—Sepsis—Carmustine—malignant glioma	0.00428	0.00818	CcSEcCtD
Prednisone—SLCO1A2—telencephalon—malignant glioma	0.00421	0.0347	CbGeAlD
Prednisone—Thrombophlebitis—Carmustine—malignant glioma	0.00414	0.0079	CcSEcCtD
Prednisone—Diabetes mellitus—Carmustine—malignant glioma	0.00412	0.00786	CcSEcCtD
Prednisone—Thrombophlebitis—Temozolomide—malignant glioma	0.004	0.00764	CcSEcCtD
Prednisone—Injury—Carmustine—malignant glioma	0.0039	0.00744	CcSEcCtD
Prednisone—Vascular purpura—Temozolomide—malignant glioma	0.00387	0.00739	CcSEcCtD
Prednisone—Amnesia—Carmustine—malignant glioma	0.00381	0.00728	CcSEcCtD
Prednisone—Amnesia—Temozolomide—malignant glioma	0.00368	0.00703	CcSEcCtD
Prednisone—Purpura—Temozolomide—malignant glioma	0.00359	0.00686	CcSEcCtD
Prednisone—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00358	0.00684	CcSEcCtD
Prednisone—Face oedema—Carmustine—malignant glioma	0.00346	0.0066	CcSEcCtD
Prednisone—Affect lability—Temozolomide—malignant glioma	0.00341	0.00651	CcSEcCtD
Prednisone—Face oedema—Temozolomide—malignant glioma	0.00334	0.00638	CcSEcCtD
Prednisone—SLCO1A2—medulla oblongata—malignant glioma	0.00331	0.0273	CbGeAlD
Prednisone—Mood swings—Temozolomide—malignant glioma	0.00328	0.00626	CcSEcCtD
Prednisone—Hypokalaemia—Carmustine—malignant glioma	0.00326	0.00622	CcSEcCtD
Prednisone—NR3C1—embryo—malignant glioma	0.00324	0.0267	CbGeAlD
Prednisone—Dry skin—Temozolomide—malignant glioma	0.00317	0.00606	CcSEcCtD
Prednisone—Muscular weakness—Carmustine—malignant glioma	0.00316	0.00603	CcSEcCtD
Prednisone—Hypokalaemia—Temozolomide—malignant glioma	0.00315	0.00602	CcSEcCtD
Prednisone—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00305	0.00583	CcSEcCtD
Prednisone—Muscular weakness—Temozolomide—malignant glioma	0.00305	0.00583	CcSEcCtD
Prednisone—SLCO1A2—midbrain—malignant glioma	0.00302	0.0249	CbGeAlD
Prednisone—Abdominal distension—Temozolomide—malignant glioma	0.00301	0.00575	CcSEcCtD
Prednisone—NR3C1—brainstem—malignant glioma	0.00297	0.0245	CbGeAlD
Prednisone—SLCO1A2—spinal cord—malignant glioma	0.00295	0.0243	CbGeAlD
Prednisone—Sweating increased—Temozolomide—malignant glioma	0.00291	0.00556	CcSEcCtD
Prednisone—ABCB1—blood vessel—malignant glioma	0.00291	0.0239	CbGeAlD
Prednisone—Neutropenia—Carmustine—malignant glioma	0.00289	0.00553	CcSEcCtD
Prednisone—Neutropenia—Temozolomide—malignant glioma	0.0028	0.00534	CcSEcCtD
Prednisone—Hyperglycaemia—Carmustine—malignant glioma	0.00279	0.00533	CcSEcCtD
Prednisone—Erectile dysfunction—Temozolomide—malignant glioma	0.00275	0.00526	CcSEcCtD
Prednisone—Depression—Carmustine—malignant glioma	0.00275	0.00526	CcSEcCtD
Prednisone—Weight increased—Temozolomide—malignant glioma	0.00272	0.0052	CcSEcCtD
Prednisone—Weight decreased—Temozolomide—malignant glioma	0.00271	0.00517	CcSEcCtD
Prednisone—Neuropathy peripheral—Carmustine—malignant glioma	0.0027	0.00517	CcSEcCtD
Prednisone—Hyperglycaemia—Temozolomide—malignant glioma	0.0027	0.00515	CcSEcCtD
Prednisone—Depression—Temozolomide—malignant glioma	0.00266	0.00508	CcSEcCtD
Prednisone—NR3C1—telencephalon—malignant glioma	0.00264	0.0217	CbGeAlD
Prednisone—Neuropathy peripheral—Temozolomide—malignant glioma	0.00261	0.00499	CcSEcCtD
Prednisone—Haemoglobin—Carmustine—malignant glioma	0.00249	0.00476	CcSEcCtD
Prednisone—Haemorrhage—Carmustine—malignant glioma	0.00248	0.00473	CcSEcCtD
Prednisone—Hallucination—Carmustine—malignant glioma	0.00246	0.00471	CcSEcCtD
Prednisone—Connective tissue disorder—Carmustine—malignant glioma	0.00243	0.00465	CcSEcCtD
Prednisone—Haemoglobin—Temozolomide—malignant glioma	0.00241	0.0046	CcSEcCtD
Prednisone—SLCO1A2—central nervous system—malignant glioma	0.00239	0.0197	CbGeAlD
Prednisone—Haemorrhage—Temozolomide—malignant glioma	0.00239	0.00457	CcSEcCtD
Prednisone—Hallucination—Temozolomide—malignant glioma	0.00238	0.00455	CcSEcCtD
Prednisone—Connective tissue disorder—Temozolomide—malignant glioma	0.00235	0.00449	CcSEcCtD
Prednisone—SLCO1A2—cerebellum—malignant glioma	0.00234	0.0193	CbGeAlD
Prednisone—Eye disorder—Carmustine—malignant glioma	0.00231	0.00442	CcSEcCtD
Prednisone—Flushing—Carmustine—malignant glioma	0.0023	0.00439	CcSEcCtD
Prednisone—Eye disorder—Temozolomide—malignant glioma	0.00224	0.00427	CcSEcCtD
Prednisone—Flushing—Temozolomide—malignant glioma	0.00222	0.00424	CcSEcCtD
Prednisone—Arrhythmia—Carmustine—malignant glioma	0.00221	0.00423	CcSEcCtD
Prednisone—Alopecia—Carmustine—malignant glioma	0.00219	0.00418	CcSEcCtD
Prednisone—Angiopathy—Temozolomide—malignant glioma	0.00217	0.00415	CcSEcCtD
Prednisone—Mental disorder—Carmustine—malignant glioma	0.00217	0.00415	CcSEcCtD
Prednisone—Immune system disorder—Temozolomide—malignant glioma	0.00216	0.00413	CcSEcCtD
Prednisone—Erythema—Carmustine—malignant glioma	0.00216	0.00412	CcSEcCtD
Prednisone—Malnutrition—Carmustine—malignant glioma	0.00216	0.00412	CcSEcCtD
Prednisone—Alopecia—Temozolomide—malignant glioma	0.00212	0.00404	CcSEcCtD
Prednisone—Mental disorder—Temozolomide—malignant glioma	0.0021	0.00401	CcSEcCtD
Prednisone—Erythema—Temozolomide—malignant glioma	0.00208	0.00398	CcSEcCtD
Prednisone—Malnutrition—Temozolomide—malignant glioma	0.00208	0.00398	CcSEcCtD
Prednisone—NR3C1—medulla oblongata—malignant glioma	0.00207	0.0171	CbGeAlD
Prednisone—Vision blurred—Carmustine—malignant glioma	0.00203	0.00388	CcSEcCtD
Prednisone—Anaemia—Carmustine—malignant glioma	0.00199	0.00381	CcSEcCtD
Prednisone—Agitation—Carmustine—malignant glioma	0.00198	0.00379	CcSEcCtD
Prednisone—Vision blurred—Temozolomide—malignant glioma	0.00196	0.00375	CcSEcCtD
Prednisone—Ill-defined disorder—Temozolomide—malignant glioma	0.00193	0.00369	CcSEcCtD
Prednisone—Anaemia—Temozolomide—malignant glioma	0.00193	0.00368	CcSEcCtD
Prednisone—Agitation—Temozolomide—malignant glioma	0.00191	0.00366	CcSEcCtD
Prednisone—Angioedema—Temozolomide—malignant glioma	0.0019	0.00364	CcSEcCtD
Prednisone—SLCO1A2—brain—malignant glioma	0.0019	0.0157	CbGeAlD
Prednisone—NR3C1—midbrain—malignant glioma	0.00189	0.0156	CbGeAlD
Prednisone—ALB—brain—malignant glioma	0.00189	0.0156	CbGeAlD
Prednisone—Malaise—Temozolomide—malignant glioma	0.00188	0.00359	CcSEcCtD
Prednisone—Vertigo—Temozolomide—malignant glioma	0.00187	0.00358	CcSEcCtD
Prednisone—Convulsion—Carmustine—malignant glioma	0.00187	0.00357	CcSEcCtD
Prednisone—Hypertension—Carmustine—malignant glioma	0.00186	0.00356	CcSEcCtD
Prednisone—NR3C1—spinal cord—malignant glioma	0.00185	0.0152	CbGeAlD
Prednisone—Myalgia—Carmustine—malignant glioma	0.00184	0.00351	CcSEcCtD
Prednisone—Anxiety—Carmustine—malignant glioma	0.00183	0.00349	CcSEcCtD
Prednisone—Convulsion—Temozolomide—malignant glioma	0.00181	0.00345	CcSEcCtD
Prednisone—Hypertension—Temozolomide—malignant glioma	0.0018	0.00344	CcSEcCtD
Prednisone—Myalgia—Temozolomide—malignant glioma	0.00177	0.00339	CcSEcCtD
Prednisone—Arthralgia—Temozolomide—malignant glioma	0.00177	0.00339	CcSEcCtD
Prednisone—Anxiety—Temozolomide—malignant glioma	0.00177	0.00338	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00176	0.00337	CcSEcCtD
Prednisone—Oedema—Carmustine—malignant glioma	0.00176	0.00336	CcSEcCtD
Prednisone—Discomfort—Temozolomide—malignant glioma	0.00175	0.00335	CcSEcCtD
Prednisone—Infection—Carmustine—malignant glioma	0.00175	0.00334	CcSEcCtD
Prednisone—ABCB1—embryo—malignant glioma	0.00173	0.0143	CbGeAlD
Prednisone—Tachycardia—Carmustine—malignant glioma	0.00172	0.00328	CcSEcCtD
Prednisone—Anaphylactic shock—Temozolomide—malignant glioma	0.0017	0.00325	CcSEcCtD
Prednisone—Oedema—Temozolomide—malignant glioma	0.0017	0.00325	CcSEcCtD
Prednisone—Infection—Temozolomide—malignant glioma	0.00169	0.00323	CcSEcCtD
Prednisone—Anorexia—Carmustine—malignant glioma	0.00168	0.0032	CcSEcCtD
Prednisone—Nervous system disorder—Temozolomide—malignant glioma	0.00167	0.00319	CcSEcCtD
Prednisone—Skin disorder—Temozolomide—malignant glioma	0.00165	0.00316	CcSEcCtD
Prednisone—Hyperhidrosis—Temozolomide—malignant glioma	0.00164	0.00314	CcSEcCtD
Prednisone—Anorexia—Temozolomide—malignant glioma	0.00162	0.0031	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Carmustine—malignant glioma	0.0016	0.00306	CcSEcCtD
Prednisone—Insomnia—Carmustine—malignant glioma	0.00159	0.00304	CcSEcCtD
Prednisone—Paraesthesia—Carmustine—malignant glioma	0.00158	0.00302	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00155	0.00296	CcSEcCtD
Prednisone—Insomnia—Temozolomide—malignant glioma	0.00154	0.00294	CcSEcCtD
Prednisone—ABCB1—retina—malignant glioma	0.00153	0.0126	CbGeAlD
Prednisone—Decreased appetite—Carmustine—malignant glioma	0.00153	0.00292	CcSEcCtD
Prednisone—Paraesthesia—Temozolomide—malignant glioma	0.00153	0.00292	CcSEcCtD
Prednisone—Constipation—Carmustine—malignant glioma	0.0015	0.00287	CcSEcCtD
Prednisone—NR3C1—central nervous system—malignant glioma	0.0015	0.0123	CbGeAlD
Prednisone—Dyspepsia—Temozolomide—malignant glioma	0.0015	0.00286	CcSEcCtD
Prednisone—Decreased appetite—Temozolomide—malignant glioma	0.00148	0.00282	CcSEcCtD
Prednisone—Fatigue—Temozolomide—malignant glioma	0.00147	0.0028	CcSEcCtD
Prednisone—NR3C1—cerebellum—malignant glioma	0.00146	0.0121	CbGeAlD
Prednisone—Constipation—Temozolomide—malignant glioma	0.00145	0.00278	CcSEcCtD
Prednisone—Feeling abnormal—Carmustine—malignant glioma	0.00145	0.00277	CcSEcCtD
Prednisone—Gastrointestinal pain—Carmustine—malignant glioma	0.00144	0.00275	CcSEcCtD
Prednisone—ABCB1—telencephalon—malignant glioma	0.00141	0.0116	CbGeAlD
Prednisone—Feeling abnormal—Temozolomide—malignant glioma	0.0014	0.00268	CcSEcCtD
Prednisone—Body temperature increased—Carmustine—malignant glioma	0.00139	0.00266	CcSEcCtD
Prednisone—Abdominal pain—Carmustine—malignant glioma	0.00139	0.00266	CcSEcCtD
Prednisone—Gastrointestinal pain—Temozolomide—malignant glioma	0.00139	0.00266	CcSEcCtD
Prednisone—Urticaria—Temozolomide—malignant glioma	0.00135	0.00258	CcSEcCtD
Prednisone—Body temperature increased—Temozolomide—malignant glioma	0.00134	0.00257	CcSEcCtD
Prednisone—Abdominal pain—Temozolomide—malignant glioma	0.00134	0.00257	CcSEcCtD
Prednisone—Hypersensitivity—Carmustine—malignant glioma	0.0013	0.00248	CcSEcCtD
Prednisone—Asthenia—Carmustine—malignant glioma	0.00126	0.00241	CcSEcCtD
Prednisone—Hypersensitivity—Temozolomide—malignant glioma	0.00125	0.00239	CcSEcCtD
Prednisone—Methyltestosterone—CYP2B6—malignant glioma	0.00123	0.282	CrCbGaD
Prednisone—Asthenia—Temozolomide—malignant glioma	0.00122	0.00233	CcSEcCtD
Prednisone—Diarrhoea—Carmustine—malignant glioma	0.0012	0.0023	CcSEcCtD
Prednisone—Pruritus—Temozolomide—malignant glioma	0.0012	0.0023	CcSEcCtD
Prednisone—NR3C1—brain—malignant glioma	0.00119	0.00979	CbGeAlD
Prednisone—Triamcinolone—BCHE—malignant glioma	0.00118	0.272	CrCbGaD
Prednisone—Dizziness—Carmustine—malignant glioma	0.00116	0.00222	CcSEcCtD
Prednisone—Diarrhoea—Temozolomide—malignant glioma	0.00116	0.00222	CcSEcCtD
Prednisone—CYP3A4—central nervous system—malignant glioma	0.00113	0.00933	CbGeAlD
Prednisone—Dizziness—Temozolomide—malignant glioma	0.00112	0.00215	CcSEcCtD
Prednisone—Vomiting—Carmustine—malignant glioma	0.00112	0.00214	CcSEcCtD
Prednisone—Rash—Carmustine—malignant glioma	0.00111	0.00212	CcSEcCtD
Prednisone—ABCB1—medulla oblongata—malignant glioma	0.00111	0.00913	CbGeAlD
Prednisone—Dermatitis—Carmustine—malignant glioma	0.00111	0.00212	CcSEcCtD
Prednisone—Headache—Carmustine—malignant glioma	0.0011	0.00211	CcSEcCtD
Prednisone—Vomiting—Temozolomide—malignant glioma	0.00108	0.00207	CcSEcCtD
Prednisone—Rash—Temozolomide—malignant glioma	0.00107	0.00205	CcSEcCtD
Prednisone—Dermatitis—Temozolomide—malignant glioma	0.00107	0.00205	CcSEcCtD
Prednisone—Headache—Temozolomide—malignant glioma	0.00107	0.00204	CcSEcCtD
Prednisone—Nausea—Carmustine—malignant glioma	0.00105	0.002	CcSEcCtD
Prednisone—ABCB1—midbrain—malignant glioma	0.00101	0.00834	CbGeAlD
Prednisone—Nausea—Temozolomide—malignant glioma	0.00101	0.00193	CcSEcCtD
Prednisone—ABCB1—spinal cord—malignant glioma	0.000989	0.00814	CbGeAlD
Prednisone—ABCB1—central nervous system—malignant glioma	0.000802	0.0066	CbGeAlD
Prednisone—ABCB1—cerebellum—malignant glioma	0.000784	0.00645	CbGeAlD
Prednisone—Dexamethasone—CYP2B6—malignant glioma	0.000691	0.158	CrCbGaD
Prednisone—ABCB1—brain—malignant glioma	0.000637	0.00524	CbGeAlD
Prednisone—Triamcinolone—PTGS2—malignant glioma	0.000545	0.125	CrCbGaD
Prednisone—Betamethasone—PTGS2—malignant glioma	0.000447	0.102	CrCbGaD
Prednisone—Dexamethasone—PTGS2—malignant glioma	0.00026	0.0596	CrCbGaD
Prednisone—ALB—Folate Metabolism—TNF—malignant glioma	0.000194	0.00084	CbGpPWpGaD
Prednisone—ALB—Hemostasis—HIST1H3B—malignant glioma	0.000189	0.000816	CbGpPWpGaD
Prednisone—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000189	0.000815	CbGpPWpGaD
Prednisone—ALB—Hemostasis—MYB—malignant glioma	0.000187	0.000809	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000187	0.000807	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000187	0.000807	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—CDKN2B—malignant glioma	0.000187	0.000806	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CYP2B6—malignant glioma	0.000186	0.000804	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000186	0.000804	CbGpPWpGaD
Prednisone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—malignant glioma	0.000185	0.000801	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—TNF—malignant glioma	0.000184	0.000797	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.000183	0.000792	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000181	0.000781	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—NCOR1—malignant glioma	0.000177	0.000765	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—VEGFA—malignant glioma	0.000172	0.000744	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—TP53—malignant glioma	0.000171	0.000741	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—IDH1—malignant glioma	0.00017	0.000736	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000168	0.000724	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—PDGFB—malignant glioma	0.000167	0.000722	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—DNMT3B—malignant glioma	0.000165	0.000715	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—SPHK1—malignant glioma	0.000165	0.000712	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.000164	0.000708	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000162	0.000701	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CYP2C18—malignant glioma	0.000161	0.000697	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—HIST1H3B—malignant glioma	0.000161	0.000694	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000159	0.000689	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—PIK3CA—malignant glioma	0.000158	0.000684	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—TNF—malignant glioma	0.000154	0.000668	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000152	0.000658	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—FN1—malignant glioma	0.000151	0.000652	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—F2—malignant glioma	0.000151	0.000652	CbGpPWpGaD
Prednisone—ALB—Metabolism—COX8A—malignant glioma	0.00015	0.000649	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—TNF—malignant glioma	0.000148	0.000638	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.000147	0.000634	CbGpPWpGaD
Prednisone—ALB—Hemostasis—H3F3A—malignant glioma	0.000146	0.000631	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—PIK3CG—malignant glioma	0.000144	0.000624	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—EGF—malignant glioma	0.000143	0.000616	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.000142	0.000614	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000141	0.00061	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.00014	0.000607	CbGpPWpGaD
Prednisone—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000139	0.000603	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000139	0.000599	CbGpPWpGaD
Prednisone—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.000138	0.000595	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—COX8A—malignant glioma	0.000135	0.000582	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—NOTCH1—malignant glioma	0.000134	0.000581	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000134	0.00058	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000134	0.000578	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—AKT2—malignant glioma	0.000132	0.000571	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—COX8A—malignant glioma	0.000131	0.000568	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GSTT1—malignant glioma	0.00013	0.000564	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—AKT1—malignant glioma	0.000129	0.000559	CbGpPWpGaD
Prednisone—ALB—Metabolism—ASMT—malignant glioma	0.000128	0.000551	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000128	0.000551	CbGpPWpGaD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	0.000127	0.000548	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—PIK3CD—malignant glioma	0.000127	0.000548	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—PPARG—malignant glioma	0.000127	0.000548	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000125	0.000539	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—H3F3A—malignant glioma	0.000124	0.000536	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PTGS1—malignant glioma	0.000122	0.000528	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000122	0.000527	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.00012	0.00052	CbGpPWpGaD
Prednisone—ALB—Hemostasis—KNG1—malignant glioma	0.00012	0.00052	CbGpPWpGaD
Prednisone—ALB—Metabolism—BCAN—malignant glioma	0.00012	0.000519	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.00012	0.000517	CbGpPWpGaD
Prednisone—ALB—Hemostasis—IFNA2—malignant glioma	0.000118	0.000509	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000117	0.000506	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—NOTCH3—malignant glioma	0.000116	0.000503	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ASMT—malignant glioma	0.000115	0.000495	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—BCHE—malignant glioma	0.000114	0.000491	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.000114	0.000491	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—RAF1—malignant glioma	0.000113	0.000489	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—SLC5A5—malignant glioma	0.000112	0.000485	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000112	0.000484	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.000112	0.000484	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ASMT—malignant glioma	0.000112	0.000483	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000112	0.000483	CbGpPWpGaD
Prednisone—ALB—Hemostasis—SOD1—malignant glioma	0.000112	0.000483	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000111	0.000482	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000111	0.000482	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—PIK3CB—malignant glioma	0.000111	0.000478	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.00011	0.000477	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.000108	0.000466	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—BCAN—malignant glioma	0.000108	0.000465	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000106	0.000459	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000105	0.000455	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—BCAN—malignant glioma	0.000105	0.000454	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—NOTCH2—malignant glioma	0.000104	0.000452	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000103	0.000447	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000103	0.000444	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PTK2—malignant glioma	0.000103	0.000443	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—IL2—malignant glioma	0.000102	0.000439	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.0001	0.000433	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	9.77e-05	0.000422	CbGpPWpGaD
Prednisone—ALB—Metabolism—IDH2—malignant glioma	9.67e-05	0.000418	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	9.41e-05	0.000407	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	9.18e-05	0.000397	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	9.12e-05	0.000394	CbGpPWpGaD
Prednisone—ALB—Metabolism—CYP2B6—malignant glioma	9.09e-05	0.000393	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GSTP1—malignant glioma	9.04e-05	0.000391	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—CDKN2B—malignant glioma	8.98e-05	0.000388	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CAT—malignant glioma	8.8e-05	0.00038	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—IDH2—malignant glioma	8.68e-05	0.000375	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	8.63e-05	0.000373	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PDGFB—malignant glioma	8.62e-05	0.000372	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—NCOR1—malignant glioma	8.52e-05	0.000368	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	8.5e-05	0.000367	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—IDH2—malignant glioma	8.47e-05	0.000366	CbGpPWpGaD
Prednisone—ALB—Metabolism—IDH1—malignant glioma	8.32e-05	0.000359	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—NCOR1—malignant glioma	8.31e-05	0.000359	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	8.19e-05	0.000354	CbGpPWpGaD
Prednisone—ALB—Hemostasis—CAV1—malignant glioma	8.16e-05	0.000353	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CYP2B6—malignant glioma	8.16e-05	0.000353	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—COX8A—malignant glioma	8.1e-05	0.00035	CbGpPWpGaD
Prednisone—ALB—Metabolism—SPHK1—malignant glioma	8.05e-05	0.000348	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYP2B6—malignant glioma	7.97e-05	0.000344	CbGpPWpGaD
Prednisone—ALB—Metabolism—CYP2C18—malignant glioma	7.88e-05	0.000341	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	7.82e-05	0.000338	CbGpPWpGaD
Prednisone—ALB—Hemostasis—F2—malignant glioma	7.77e-05	0.000336	CbGpPWpGaD
Prednisone—ALB—Hemostasis—FN1—malignant glioma	7.77e-05	0.000336	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	7.65e-05	0.00033	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—IDH1—malignant glioma	7.46e-05	0.000323	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PIK3CG—malignant glioma	7.44e-05	0.000321	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	7.43e-05	0.000321	CbGpPWpGaD
Prednisone—ALB—Hemostasis—EGF—malignant glioma	7.35e-05	0.000318	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PTPN11—malignant glioma	7.31e-05	0.000316	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—IDH1—malignant glioma	7.29e-05	0.000315	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	7.28e-05	0.000315	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—MYC—malignant glioma	7.23e-05	0.000312	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	7.22e-05	0.000312	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—SPHK1—malignant glioma	7.22e-05	0.000312	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CYP2C18—malignant glioma	7.08e-05	0.000306	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—SPHK1—malignant glioma	7.05e-05	0.000305	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYP2C18—malignant glioma	6.91e-05	0.000299	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ASMT—malignant glioma	6.89e-05	0.000298	CbGpPWpGaD
Prednisone—ALB—Hemostasis—AKT2—malignant glioma	6.8e-05	0.000294	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CAV1—malignant glioma	6.78e-05	0.000293	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	6.77e-05	0.000293	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	6.74e-05	0.000291	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	6.67e-05	0.000288	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	6.64e-05	0.000287	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PIK3CD—malignant glioma	6.54e-05	0.000283	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	6.53e-05	0.000282	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—BCAN—malignant glioma	6.48e-05	0.00028	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.47e-05	0.00028	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—NOTCH1—malignant glioma	6.47e-05	0.00028	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	6.42e-05	0.000277	CbGpPWpGaD
Prednisone—ALB—Metabolism—GSTT1—malignant glioma	6.38e-05	0.000276	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PIK3CG—malignant glioma	6.17e-05	0.000267	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—PPARG—malignant glioma	6.1e-05	0.000264	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	6.08e-05	0.000263	CbGpPWpGaD
Prednisone—ALB—Metabolism—PTGS1—malignant glioma	5.97e-05	0.000258	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PPARG—malignant glioma	5.96e-05	0.000257	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	5.95e-05	0.000257	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	5.87e-05	0.000254	CbGpPWpGaD
Prednisone—ALB—Hemostasis—RAF1—malignant glioma	5.84e-05	0.000252	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GSTT1—malignant glioma	5.72e-05	0.000247	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PIK3CB—malignant glioma	5.7e-05	0.000246	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GSTT1—malignant glioma	5.59e-05	0.000241	CbGpPWpGaD
Prednisone—ALB—Metabolism—BCHE—malignant glioma	5.55e-05	0.00024	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	5.51e-05	0.000238	CbGpPWpGaD
Prednisone—ALB—Metabolism—SLC5A5—malignant glioma	5.49e-05	0.000237	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PIK3CD—malignant glioma	5.43e-05	0.000234	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	5.42e-05	0.000234	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PTGS1—malignant glioma	5.36e-05	0.000232	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	5.34e-05	0.000231	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PTGS1—malignant glioma	5.23e-05	0.000226	CbGpPWpGaD
Prednisone—ALB—Hemostasis—IL2—malignant glioma	5.23e-05	0.000226	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—IDH2—malignant glioma	5.22e-05	0.000226	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	5.19e-05	0.000224	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.14e-05	0.000222	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	5.05e-05	0.000218	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—BCHE—malignant glioma	4.99e-05	0.000215	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—SLC5A5—malignant glioma	4.92e-05	0.000213	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP2B6—malignant glioma	4.91e-05	0.000212	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—BCHE—malignant glioma	4.87e-05	0.00021	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—SLC5A5—malignant glioma	4.81e-05	0.000208	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PIK3CB—malignant glioma	4.73e-05	0.000204	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PTGS2—malignant glioma	4.69e-05	0.000203	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.66e-05	0.000201	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.61e-05	0.000199	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—IDH1—malignant glioma	4.49e-05	0.000194	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.48e-05	0.000194	CbGpPWpGaD
Prednisone—ALB—Hemostasis—VEGFA—malignant glioma	4.45e-05	0.000192	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	4.43e-05	0.000191	CbGpPWpGaD
Prednisone—ALB—Metabolism—GSTP1—malignant glioma	4.42e-05	0.000191	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—SPHK1—malignant glioma	4.34e-05	0.000188	CbGpPWpGaD
Prednisone—ALB—Metabolism—CAT—malignant glioma	4.3e-05	0.000186	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP2C18—malignant glioma	4.26e-05	0.000184	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PTEN—malignant glioma	4.09e-05	0.000177	CbGpPWpGaD
Prednisone—ALB—Metabolism—NCOR1—malignant glioma	4.06e-05	0.000176	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.02e-05	0.000174	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GSTP1—malignant glioma	3.97e-05	0.000171	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GSTP1—malignant glioma	3.87e-05	0.000167	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CAT—malignant glioma	3.86e-05	0.000167	CbGpPWpGaD
Prednisone—ALB—Hemostasis—KRAS—malignant glioma	3.78e-05	0.000163	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CAT—malignant glioma	3.77e-05	0.000163	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—NCOR1—malignant glioma	3.65e-05	0.000158	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—NCOR1—malignant glioma	3.56e-05	0.000154	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—MYC—malignant glioma	3.48e-05	0.00015	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PIK3CA—malignant glioma	3.47e-05	0.00015	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GSTT1—malignant glioma	3.44e-05	0.000149	CbGpPWpGaD
Prednisone—ALB—Hemostasis—TP53—malignant glioma	3.36e-05	0.000145	CbGpPWpGaD
Prednisone—ALB—Metabolism—CAV1—malignant glioma	3.31e-05	0.000143	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PTGS1—malignant glioma	3.22e-05	0.000139	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.16e-05	0.000137	CbGpPWpGaD
Prednisone—ALB—Metabolism—PIK3CG—malignant glioma	3.02e-05	0.00013	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—BCHE—malignant glioma	3e-05	0.00013	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CAV1—malignant glioma	2.97e-05	0.000128	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—SLC5A5—malignant glioma	2.96e-05	0.000128	CbGpPWpGaD
Prednisone—ALB—Metabolism—PPARG—malignant glioma	2.91e-05	0.000126	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CAV1—malignant glioma	2.9e-05	0.000125	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PIK3CA—malignant glioma	2.88e-05	0.000125	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.84e-05	0.000123	CbGpPWpGaD
Prednisone—ALB—Hemostasis—AKT1—malignant glioma	2.84e-05	0.000123	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PIK3CG—malignant glioma	2.71e-05	0.000117	CbGpPWpGaD
Prednisone—ALB—Metabolism—PIK3CD—malignant glioma	2.65e-05	0.000115	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PIK3CG—malignant glioma	2.64e-05	0.000114	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PPARG—malignant glioma	2.61e-05	0.000113	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PPARG—malignant glioma	2.55e-05	0.00011	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—AKT1—malignant glioma	2.41e-05	0.000104	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GSTP1—malignant glioma	2.39e-05	0.000103	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PIK3CD—malignant glioma	2.38e-05	0.000103	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—AKT1—malignant glioma	2.35e-05	0.000102	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PIK3CD—malignant glioma	2.32e-05	0.0001	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CAT—malignant glioma	2.32e-05	0.0001	CbGpPWpGaD
Prednisone—ALB—Metabolism—PIK3CB—malignant glioma	2.31e-05	9.99e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PTGS2—malignant glioma	2.29e-05	9.89e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—NCOR1—malignant glioma	2.19e-05	9.47e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PIK3CB—malignant glioma	2.07e-05	8.96e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PTGS2—malignant glioma	2.06e-05	8.88e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PIK3CB—malignant glioma	2.02e-05	8.75e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PTGS2—malignant glioma	2.01e-05	8.67e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PTEN—malignant glioma	2e-05	8.63e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PTEN—malignant glioma	1.79e-05	7.75e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CAV1—malignant glioma	1.79e-05	7.72e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PTEN—malignant glioma	1.75e-05	7.56e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.63e-05	7.04e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PPARG—malignant glioma	1.57e-05	6.79e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.43e-05	6.18e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PIK3CA—malignant glioma	1.41e-05	6.09e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PIK3CA—malignant glioma	1.26e-05	5.46e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.25e-05	5.39e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PTGS2—malignant glioma	1.24e-05	5.34e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PIK3CA—malignant glioma	1.23e-05	5.33e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—AKT1—malignant glioma	1.15e-05	4.97e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PTEN—malignant glioma	1.08e-05	4.66e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—AKT1—malignant glioma	1.03e-05	4.46e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—AKT1—malignant glioma	1.01e-05	4.36e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PIK3CA—malignant glioma	7.6e-06	3.29e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—AKT1—malignant glioma	6.21e-06	2.68e-05	CbGpPWpGaD
